Molecular abnormalities in ovarian carcinoma: clinical, morphological and therapeutic correlates.
about
Bevacizumab in combination with chemotherapy in platinum-sensitive ovarian cancer.Epithelial-to-Mesenchymal Transition in the Female Reproductive Tract: From Normal Functioning to Disease Pathology.Estrogen signaling crosstalk: Implications for endocrine resistance in ovarian cancer.Expression of mitochondrial regulators PGC1α and TFAM as putative markers of subtype and chemoresistance in epithelial ovarian carcinomaHER2 amplification and clinicopathological characteristics in a large Asian cohort of rare mucinous ovarian cancer.Prognostic significance of specific anti-WT1 IgG antibody level in plasma in patients with ovarian carcinomaReplication study for the association of seven genome- GWAS-identified Loci with susceptibility to ovarian cancer in the Polish population.Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms.Intra-tumor heterogeneity in TP53 null High Grade Serous Ovarian Carcinoma progressionA qualitative study comparing the assay performance characteristics between the 2007 and the 2013 American Society for Clinical Oncology and College of American Pathologists HER2 scoring methods in mucinous epithelial ovarian cancer.Morphologic and Molecular Characteristics of Mixed Epithelial Ovarian Cancers.Novel high-grade serous epithelial ovarian cancer cell lines that reflect the molecular diversity of both the sporadic and hereditary disease'BRCAness' and its implications for platinum action in gynecologic cancer.Time to diagnosis of Type I or II invasive epithelial ovarian cancers: a multicentre observational study using patient questionnaire and primary care records.Annexin A4 is involved in proliferation, chemo-resistance and migration and invasion in ovarian clear cell adenocarcinoma cells.Phosphoproteomics of Primary Cells Reveals Druggable Kinase Signatures in Ovarian Cancer.Ovarian carcinoma histotype determination is highly reproducible, and is improved through the use of immunohistochemistry.Assignment of primary site in high-grade serous tubal, ovarian and peritoneal carcinoma: a proposal.EGF-Induced Connexin43 Negatively Regulates Cell Proliferation in Human Ovarian Cancer.Crk-like adapter protein regulates CCL19/CCR7-mediated epithelial-to-mesenchymal transition via ERK signaling pathway in epithelial ovarian carcinomas.Frequent translocations of 11q13.2 and 19p13.2 in ovarian cancer.The changing landscape of gynaecological cancer diagnosis: implications for histopathological practice in the 21st century.Risk-reducing salpingectomy: Let us be opportunistic.Preclinical Models of Ovarian Cancer: Pathogenesis, Problems, and Implications for Prevention.A Pathological Study Using 2014 WHO Criteria Reveals Poor Prognosis of Grade 3 Ovarian Endometrioid Carcinomas.Comparative study of endometrioid borderline ovarian tumor with and without endometriosis
P2860
Q33800676-7F8FBA43-A3AD-4DEF-9657-7B4FB70EBF32Q33872622-553B5A0A-050E-4A93-982B-2ECEA344688BQ34022694-1EDDF908-66C6-4A1C-A4F2-F924901854C7Q34223682-845B2974-BB7C-41AC-B5EA-BE5FD87D5E12Q34688984-713072D4-CE2C-40F5-A56D-DA39E73D57A9Q35000449-8112F905-3660-4EF6-88B2-8E2F616188C6Q35578071-31D3D428-1DE7-45C8-826A-E33762EFECFFQ35634450-5EDD6996-9EF5-45E1-994D-B3C7D41F5544Q35856294-E0740BA3-3DBC-4E4A-8C0A-FFC2B1BE6E37Q36152629-BC3E569E-3787-4DD5-91EE-051C7DEC14A3Q36157106-73C8F112-B738-4A1C-93C6-5D63808B25B8Q36248459-51FD3A98-054A-4CE1-B5C3-0E566FF1B53CQ36380704-71FEC4B4-031F-4874-9C03-6A1B59D8D9AAQ36866311-BA943691-5122-4EC1-A152-8BE1FE4482F2Q37296914-6ACE6DE2-B728-444E-8930-A0AA613E534EQ37739177-92E3CA15-23E2-4F83-863C-66BF60382759Q38170493-9F1857C5-4AF6-4058-A831-72A101639C35Q38198705-64AB8984-780D-4048-A828-B22CA2619CAAQ38868835-7F7E07CD-BFB5-476B-81B0-F30C06785D26Q38914872-1D76E651-E010-4C36-9F87-A7E676C93CC9Q39016657-6A707732-A86A-4882-804C-0021B54D2FB6Q39037647-4B667926-59C6-4FEC-B1B5-DED38FBDEF7DQ39196159-2995524F-F0D3-43FA-A0AF-DBD3F0D9C3ACQ39441988-92A4B99E-8350-480A-8810-2C7ABFE09F6AQ55465801-CFEC90F8-76F8-4F2B-BABE-78E1CBA118E4Q58788504-D2504E0F-18D2-4A97-9EAA-CD89570B5BE0
P2860
Molecular abnormalities in ovarian carcinoma: clinical, morphological and therapeutic correlates.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Molecular abnormalities in ova ...... al and therapeutic correlates.
@en
type
label
Molecular abnormalities in ova ...... al and therapeutic correlates.
@en
prefLabel
Molecular abnormalities in ova ...... al and therapeutic correlates.
@en
P2093
P2860
P356
P1433
P1476
Molecular abnormalities in ova ...... al and therapeutic correlates.
@en
P2093
Ananta Gurung
C Blake Gilks
Jason Morin
Tawny Hung
P2860
P356
10.1111/HIS.12033
P577
2013-01-01T00:00:00Z